Comments
Shares of Torrent Pharmaceuticals and Biocon will see buying interest on Thursday as their proposals for foreign direct investment were approved by the government. Torrent Pharma’s ₹3,000-crore proposal for the increasing FII limit to 35 per cent from 13.09 per cent and Syngene International’s (Biocon subsidiary) proposal to raise FDI of around ₹930 crore by raising the FII limit to 44 per cent from 10 per cent were approved.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.